These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15404224)

  • 21. Recombinant-attenuated
    Ding K; Shang K; Yu ZH; Yu C; Jia YY; He L; Liao CS; Li J; Zhang CJ; Li YJ; Wu TC; Cheng XC
    J Vet Sci; 2018 Mar; 19(2):232-241. PubMed ID: 29032660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Avian influenza virus and Newcastle disease virus (NDV) surveillance in commercial breeding farm in China and the characterization of Class I NDV isolates.
    Hu B; Huang Y; He Y; Xu C; Lu X; Zhang W; Meng B; Yan S; Zhang X
    Vet Microbiol; 2010 Jul; 144(1-2):82-6. PubMed ID: 20133090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inclusion body formation with Newcastle disease and mumps viruses in cultures of chick embryo cells.
    BRANDT CD
    Virology; 1958 Apr; 5(2):177-91. PubMed ID: 13544099
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of the HN Antigenic Difference between the Vaccine Strain and the Challenge Strain of Newcastle Disease Virus on Virus Shedding and Transmission.
    Liu J; Zhu J; Xu H; Li J; Hu Z; Hu S; And XW; Liu X
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28809802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of infections caused by mumps and Newcastle disease viruses. II. Some properties of specific and non-specific serum hemagglutination inhibitor components.
    WENNER HA; MONLEY A; JENSON MH
    J Immunol; 1952 Apr; 68(4):357-68. PubMed ID: 14946376
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative tests on hemagglutination inhibition with Newcastle virus and with mumps virus in sera of patients with epidemic parotitis].
    MONACI V
    Boll Ist Sieroter Milan; 1953; 32(7-8):276-9. PubMed ID: 13105837
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential inhibition of virus hemagglutination by chlorophyllin.
    DUNHAM WB
    Proc Soc Exp Biol Med; 1954 Nov; 87(2):431-3. PubMed ID: 13237265
    [No Abstract]   [Full Text] [Related]  

  • 28. Mechanism of production of pulmonary lesions in mice by Newcastle disease virus (NDV).
    GINSBERG HS
    J Exp Med; 1951 Sep; 94(3):191-211. PubMed ID: 14861378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Previous infection with virulent strains of Newcastle disease virus reduces highly pathogenic avian influenza virus replication, disease, and mortality in chickens.
    Costa-Hurtado M; Afonso CL; Miller PJ; Shepherd E; Cha RM; Smith D; Spackman E; Kapczynski DR; Suarez DL; Swayne DE; Pantin-Jackwood MJ
    Vet Res; 2015 Sep; 46(1):97. PubMed ID: 26394750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chimeric Newcastle disease virus-vectored vaccine protects chickens against H9N2 avian influenza virus in the presence of pre-existing NDV immunity.
    Liu J; Xue L; Hu S; Cheng H; Deng Y; Hu Z; Wang X; Liu X
    Arch Virol; 2018 Dec; 163(12):3365-3371. PubMed ID: 30187143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study of infections caused by mumps and Newcastle disease viruses. I. Specific and non-specific serologic relations.
    WENNER HA; JENSON MH; MONLEY A
    J Immunol; 1952 Apr; 68(4):343-56. PubMed ID: 14946375
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on persistent infections of tissue cultures. II. Nature of the resistance to vesicular stomatitis virus.
    BERGS VV; HENLE G; DEINHARDT F; HENLE W
    J Exp Med; 1958 Oct; 108(4):561-72. PubMed ID: 13575684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assembly and immunological properties of a bivalent virus-like particle (VLP) for avian influenza and Newcastle disease.
    Shen H; Xue C; Lv L; Wang W; Liu Q; Liu K; Chen X; Zheng J; Li X; Cao Y
    Virus Res; 2013 Dec; 178(2):430-6. PubMed ID: 24050994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection and differentiation of infected from vaccinated animals by an inactivated recombinant Newcastle disease virus/avian influenza H5 vaccine.
    Lozano-Dubernard B; Soto-Priante E; Sarfati-Mizrahi D; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
    Avian Dis; 2010 Mar; 54(1 Suppl):242-5. PubMed ID: 20521639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular and phylogenetic characterization based on the complete genome of a virulent pathotype of Newcastle disease virus isolated in the 1970s in Brazil.
    Fernandes CC; Varani AM; Lemos EG; de Miranda VF; Silva KR; Fernando FS; Montassier MF; Montassier HJ
    Infect Genet Evol; 2014 Aug; 26():160-7. PubMed ID: 24865799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and genetic characterization of avian influenza viruses and a Newcastle disease virus from wild birds in Barbados: 2003-2004.
    Douglas KO; Lavoie MC; Kim LM; Afonso CL; Suarez DL
    Avian Dis; 2007 Sep; 51(3):781-7. PubMed ID: 17992942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune responses and protection against H5N1 highly pathogenic avian influenza virus induced by the Newcastle disease virus H5 vaccine in ducks.
    Ferreira HL; Pirlot JF; Reynard F; van den Berg T; Bublot M; Lambrecht B
    Avian Dis; 2012 Dec; 56(4 Suppl):940-8. PubMed ID: 23402116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-thermal plasma for inactivated-vaccine preparation.
    Wang G; Zhu R; Yang L; Wang K; Zhang Q; Su X; Yang B; Zhang J; Fang J
    Vaccine; 2016 Feb; 34(8):1126-32. PubMed ID: 26529075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus.
    Kim SH; Paldurai A; Samal SK
    Virology; 2017 Mar; 503():31-36. PubMed ID: 28110247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electronic microarray assays for avian influenza and Newcastle disease virus.
    Lung O; Beeston A; Ohene-Adjei S; Pasick J; Hodko D; Hughes KB; Furukawa-Stoffer T; Fisher M; Deregt D
    J Virol Methods; 2012 Nov; 185(2):244-53. PubMed ID: 22796283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.